Home
About
Overview
Sharing Data
ORCID
Help
History (23)
The randomized discontinuation trial: a phase II design to assess growth-inhibitory agents.
Multimedia
A case of dual-mechanism immune-related anaemia in a patient with metastatic melanoma treated with nivolumab and ipilimumab.
Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401.
Fast Forward - Neoadjuvant Cancer Immunotherapy.
See All 23 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Fast Forward - Neoadjuvant Cancer Immunotherapy.
Fast Forward - Neoadjuvant Cancer Immunotherapy. N Engl J Med. 2018 05 24; 378(21):2034-2035.
View in:
PubMed
subject areas
Humans
Immunotherapy
Neoadjuvant Therapy
Neoplasms
authors with profiles
Thomas Gajewski